No Data
No Data
US MOVERS&SHAKERS Sep 23-Sep 27, 2024
TD Cowen Maintains Regeneron Pharmaceuticals(REGN.US) With Buy Rating, Maintains Target Price $1,230
S&P 500 Extends Winning Streak to Third Week as Materials Sector Climbs
News Highlights: Top Company News of the Day - Friday at 1 PM ET
Regeneron Pharmaceuticals Suffers Worst Month in Two Years After Legal Setback
Express News | Regeneron Pharmaceuticals Shares up 1.9% After US FDA Approves Co and Partner Sanofi's Drug to Treat 'smoker's Lung'
No Data
No Data